For research use only. Not for therapeutic Use.
FC-668(Cat No.:I027317)is an experimental drug being developed for the treatment of various cancers, particularly those with high unmet medical needs. It is a selective inhibitor of the FAK (focal adhesion kinase) pathway, which plays a key role in cancer cell survival, migration, and metastasis. By targeting FAK, FC-668 aims to inhibit tumor growth and prevent the spread of cancer cells to other parts of the body. Early-stage studies suggest that FC-668 may enhance the effectiveness of existing therapies, though further clinical trials are required to confirm its safety and efficacy in patients.
Catalog Number | I027317 |
CAS Number | 2014-31-5 |
Synonyms | FC 668; FC668; FC-668 |
Molecular Formula | C15H23Cl3N2O2 |
Purity | 98% |
Solubility | Soluble in DMSO |
Appearance | Solid powder |
Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
IUPAC Name | (2-chloro-6-methylphenyl) 2-(4-methylpiperazin-1-yl)propanoate;dihydrochloride |
InChI | InChI=1S/C15H21ClN2O2.2ClH/c1-11-5-4-6-13(16)14(11)20-15(19)12(2)18-9-7-17(3)8-10-18;;/h4-6,12H,7-10H2,1-3H3;2*1H |
InChIKey | MKCJSDJZKHOKBH-UHFFFAOYSA-N |
SMILES | CC1=C(C(=CC=C1)Cl)OC(=O)C(C)N2CCN(CC2)C.Cl.Cl |